Results 71 to 80 of about 1,690 (152)

Dislipidemias, ¿qué hay de nuevo?

Revista del Hospital Italiano de Buenos Aires
En los últimos años han surgido algunas investigaciones y guías de práctica clínica relacionadas con el diagnóstico y tratamiento de las dislipidemias, que aportaron nuevos conocimientos (y controversias) sobre dicha problemática.
Walter Masson
doaj  

Role of S-palmitoylation in digestive system diseases

Cell Death Discovery
Digestive system diseases, including liver diseases, gastrointestinal cancers, and inflammatory bowel diseases, pose major health challenges worldwide.
Hanqing Li, Qiuxiang Yuan, Shuangshuang Wang, Tao Yu, Xingsi Qi   +4 more
doaj   +1 more source

A machine-learning algorithm using claims data to identify patients with homozygous familial hypercholesterolemia

Scientific Reports
Homozygous familial hypercholesterolemia (HoFH) is an underdiagnosed and undertreated ultra-rare disease. We utilized claims data from the Komodo Healthcare Map database to develop a machine-learning model to identify potential HoFH patients.
Jing Gu, Matthew Epland, Xinshuo Ma, Jina Park, Robert J. Sanchez, Ying Li   +5 more
doaj   +1 more source

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia

Atherosclerosis Plus, 2023
J. Cegla, D. Larrey, L. D’Erasmo, S. O’Brien, M. Arca   +4 more
doaj   +1 more source

The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production. [PDF]

Emerg Microbes Infect
Gautam A, Zhong L, Ogire E, Bodoirat S, Riedmiller I, Sander WJ, Boson B, Gandhi A, Burlaud-Gaillard J, Amirache F, Legros V, Roingeard P, Lotteau V, Mathieu C, Cosset FL, Denolly S.   +15 more
europepmc   +1 more source

TM9SF1 Aggravates Liver Ischemia-Reperfusion Injury by Promoting Autophagy. [PDF]

Inflammation
Wu T, Li W, Zhu Y, Liu X, Yu H, Li H, Zhang J, Tang H, Ding M, Guo W.   +9 more
europepmc   +1 more source

Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study

Atherosclerosis Plus, 2022
J. Cegla, L. d’Erasmo, K. Steward, A. di Costanzo, E. Boersma, M. Arca, J. Roeters van Lennep   +6 more
doaj   +1 more source

Baseline characteristics and response to evinacumab in females and males with homozygous familial hypercholesterolemia in the ELIPSE OLE study. [PDF]

Am J Prev Cardiol
Brisson D, Wiegman A, Waldron A, Kainth P, Raal FJ, Gaudet D.   +5 more
europepmc   +1 more source

Severe polyarterial involvement in a 16-year-old with homozygous familial hypercholesterolaemia: a case report. [PDF]

Eur Heart J Case Rep
Benabdellah M, Mesfioui MB, El Ouartassi H, El Boussaadani B, Raissuni Z.   +4 more
europepmc   +1 more source

Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia. [PDF]

JACC Case Rep
Alkhairy A, Xiang P, Khoo JK, Taylor CM, Francis GA.   +4 more
europepmc   +1 more source